Cargando…
An ex vivo Tissue Culture Model for the Assessment of Individualized Drug Responses in Prostate and Bladder Cancer
Urological malignancies, including prostate and bladder carcinoma, represent a major clinical problem due to the frequent occurrence of therapy resistance and the formation of incurable distant metastases. As a result, there is an urgent need for versatile and predictive disease models for the asses...
Autores principales: | van de Merbel, Arjanneke F., van der Horst, Geertje, van der Mark, Maaike H., van Uhm, Janneke I. M., van Gennep, Erik J., Kloen, Peter, Beimers, Lijkele, Pelger, Rob C. M., van der Pluijm, Gabri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176278/ https://www.ncbi.nlm.nih.gov/pubmed/30333957 http://dx.doi.org/10.3389/fonc.2018.00400 |
Ejemplares similares
-
Cationic amphiphilic drugs as potential anticancer therapy for bladder cancer
por: van der Horst, Geertje, et al.
Publicado: (2020) -
The aldehyde dehydrogenase enzyme 7A1 is functionally involved in prostate cancer bone metastasis
por: van den Hoogen, Christel, et al.
Publicado: (2011) -
Targeting of Alpha-V Integrins Reduces Malignancy of Bladder Carcinoma
por: van der Horst, Geertje, et al.
Publicado: (2014) -
Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth In Vivo
por: Kroon, Jan, et al.
Publicado: (2015) -
Reovirus mutant jin-3 exhibits lytic and immune-stimulatory effects in preclinical human prostate cancer models
por: van de Merbel, Arjanneke F., et al.
Publicado: (2021)